Tur­moil at CBER: Pe­ter Marks grabs con­trol of FDA's Of­fice of Vac­cines ahead of 2 key ca­reer leader de­par­tures

FDA’s top vac­cine of­fi­cial Pe­ter Marks is pulling the plug on a months-long tran­si­tion for two top ca­reer vac­cine of­fi­cials who abrupt­ly called it quits in late Au­gust.

Mar­i­on Gru­ber, di­rec­tor of the FDA’s Of­fice of Vac­cines Re­search & Re­view and 32-year vet­er­an of the agency, her deputy di­rec­tor Phil Krause, an­nounced their de­par­tures and then raised con­cerns with Covid-19 boost­er shots ahead of and dur­ing a re­cent Covid-19 boost­er vac­cine ad­vi­so­ry com­mit­tee.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER